trending Market Intelligence /marketintelligence/en/news-insights/trending/ejwMjSDt7Qz4a-H8l0OVtw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Flexion Therapeutics starts common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Flexion Therapeutics starts common stock offering

Flexion Therapeutics Inc. started an underwritten public offering for 4 million common shares.

The specialty pharmaceutical company plans to grant underwriters an option to buy up to an additional 15% of the shares offered.

Net proceeds will be used to fund manufacturing and commercialization of company's drug Zilretta, product pipeline development, and for working capital and general corporate purposes.

Wells Fargo Securities, BMO Capital Markets and RBC Capital Markets are acting as joint book-running managers.